Abonnement à la biblothèque: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Publication de 6  numéros par an

ISSN Imprimer: 1045-4403

ISSN En ligne: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Development of Gene-Based Therapies for Cartilage Repair

Volume 12, Numéro 4, 2002, 16 pages
DOI: 10.1615/CritRevEukaryotGeneExpr.v12.i4.20
Get accessGet access

RÉSUMÉ

Articular cartilage is particularly vulnerable to injury and degenerative conditions, and has a limited capacity for self-repair. Although current clinical procedures cannot restore a normal articular surface, there are a growing number of proteins that may be used to augment a repair process, or protect cartilage from degeneration. Because proteins are often difficult to administer effectively, gene therapy approaches are being developed to provide their sustained synthesis at sites of injury or disease.
To promote cartilage repair, cDNAs can be targeted to synovium, or cartilage. Gene transfer to the synovium is generally considered more suitable for chondroprotective therapies that rely on expression of large amounts of anti-inflammatory mediators. The delivery of genes to cartilage defects to promote enhanced repair can be performed by either direct administration of gene delivery vectors, or by implantation of genetically modified chondrogenic cells. Variations of these methods have been used to demonstrate that exogenous cDNAs encoding growth factors can be delivered locally to sites of cartilage damage where they are expressed at physiologically relevant levels. Data is beginning to emerge that suggests that delivery and expression of these genes can influence a repair response toward the synthesis of normal articular cartilage in vivo. This article reviews the current status of gene delivery for cartilage healing and presents some of the remaining challenges.

CITÉ PAR
  1. Evans Christopher H., Gene therapies for osteoarthritis, Current Rheumatology Reports, 6, 1, 2004. Crossref

  2. Ward BB, Brown SE, Krebsbach PH, Bioengineering strategies for regeneration of craniofacial bone: a review of emerging technologies, Oral Diseases, 16, 8, 2010. Crossref

  3. Evans Christopher H, Ghivizzani Steven C, Robbins Paul D, THE 2003 NICOLAS ANDRY AWARD: Orthopaedic Gene Therapy, Clinical Orthopaedics and Related Research, 429, 2004. Crossref

  4. Daher Robert J., Chahine Nadeen O., Greenberg Andrew S., Sgaglione Nicholas A., Grande Daniel A., New methods to diagnose and treat cartilage degeneration, Nature Reviews Rheumatology, 5, 11, 2009. Crossref

  5. Schek RM, Taboas JM, Hollister SJ, Krebsbach PH, Tissue engineering osteochondral implants for temporomandibular joint repair, Orthodontics and Craniofacial Research, 8, 4, 2005. Crossref

  6. Kessler Michael W., Ackerman George, Dines Joshua S., Grande Daniel, Emerging Technologies and Fourth Generation Issues in Cartilage Repair, Sports Medicine and Arthroscopy Review, 16, 4, 2008. Crossref

  7. H. Evans Christopher, Ghivizzani Steven C., Robbins Paul D., Gene therapy for arthritis: What next?, Arthritis & Rheumatism, 54, 6, 2006. Crossref

  8. Schek Rachel M., Taboas Juan M., Segvich Sharon J., Hollister Scott J., Krebsbach Paul H., Engineered Osteochondral Grafts Using Biphasic Composite Solid Free-Form Fabricated Scaffolds, Tissue Engineering, 10, 9-10, 2004. Crossref

  9. Smith Kevin R, Gene therapy: theoretical and bioethical concepts, Archives of Medical Research, 34, 4, 2003. Crossref

  10. Fuentes-Boquete Isaac Manuel, del Carmen Arufe Gonda María, Díaz Prado Silvia María, Hermida Gómez Tamara, de Toro Santos Francisco Javier, Blanco García Francisco Javier, Tratamiento de lesiones del cartílago articular con terapia celular, Reumatología Clínica, 3, 2007. Crossref

  11. Kim Hubert T., Zaffagnini Stefano, Mizuno Shuichi, Abelow Stephen, Safran Marc R., A Peek Into the Possible Future of Management of Articular Cartilage Injuries: Gene Therapy and Scaffolds for Cartilage Repair, Journal of Orthopaedic & Sports Physical Therapy, 36, 10, 2006. Crossref

  12. Evans Christopher H., Ghivizzani Steven C., Herndon James H., Robbins Paul D., Gene Therapy for the Treatment of Musculoskeletal Diseases, Journal of the American Academy of Orthopaedic Surgeons, 13, 4, 2005. Crossref

  13. Fliefel Riham, Kühnisch Jan, Ehrenfeld Michael, Otto Sven, Gene Therapy for Bone Defects in Oral and Maxillofacial Surgery: A Systematic Review and Meta-Analysis of Animal Studies, Stem Cells and Development, 26, 4, 2017. Crossref

  14. Gouze Jean-Noël, Evans Christopher H., Ghivizzani Steven C., Gouze Elvire, Application des techniques de thérapie génique aux maladies ostéo-articulaires, médecine/sciences, 23, 3, 2007. Crossref

  15. Evans CH, Gouze JN, Gouze E, Robbins PD, Ghivizzani SC, Osteoarthritis gene therapy, Gene Therapy, 11, 4, 2004. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain